AUDUSD
The Dollar, Yen and Swiss franc have outperformed amid a backdrop of tumbling stock markets in Asia and Europe, with risk aversion picking up on news of a continued rise in coronavirus infections outside China, particularly in South Korea, the Mideast and in Italy. Many countries in the Mideast have imposed travel restrictions, while the rise in infections in Italy raised the spectre of the virus gaining a foothold in Europe. Italy now has the second highest confirmed cases of COVID-19 infections outside China, second to South Korea and overtaking Hong Kong and Singapore. For those looking at the bigger picture, and cause of optimism, there remains scientific conjecture that the virus will naturally weaken a it spreads (a lowering in the “zoonotic force of inflection” or weakening in the rate of transmissibility, as is typical in virus outbreaks), as highlighted by a report in the Lancet Journal, with April seen as likely to mark the point of peak contagion. Also, the data shows that the death rate remains at about 2%, similar to flu and cold viruses, with most infected people making a full recovery.
However, there is, rightly or wrongly, an air of panic, and the economic impact of measures being taken are starting to show in data. The narrow trade-weighted USD index recouped about half of Friday’s losses in rising to 99.63. The Dollar remains the strongest currency on the year-to-date, relative to the other main currencies, showing net gains over over 6% against the weakest, the Australian and New Zealand dollars. The relative robustness of the US economy, coupled with the safe haven appeal of US Treasuries, have been underpinning the Greenback. AUDUSD printed a fresh 11-year low at 0.6585. USDJPY ebbed back to levels around 111.50, down from the 10-month high seen last week at 112.22.
Click here to access the HotForex Economic Calendar
Stuart Cowell
Head Market Analyst
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
